packageAfelimomab

afelimomab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Afelimomab is a monoclonal antibody that blocks tumor necrosis factor alpha and was investigated as a treatment for severe infection with widespread inflammation (sepsis). It remains experimental and was never approved for routine medical use.

Summary written by glm-5.3-flash from Wikidata Q3606143 and the WHO ATC classification; not checked by a person.

name:afelimomab
ATC codes:L04AB03
DrugBank:DB04956
Wikidata:Q3606143

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown